Case Report Published on 08 Mar 2024 Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study in Pediatric Endocrinology Angham AlmutairBeshaier Almulhem Frontiers in Endocrinology doi 10.3389/fendo.2024.1294264 6,320 views 7 citations